A drug dealer organizes a fentanyl smuggling operation between Canada and the United States, an architect recovering from an oxycontin addiction searches for the truth about his son's involvement in a drug addict, and a university professor grapples with unexpected revelations about his employer, an influential pharmaceutical company, bringing a new "non — addictive" painkiller to market.